Adrenomyeloneuropathy (AMN) is an adult form of the peroxisomal disease X-linked adrenoleukodystrophy (X-ALD, see this term), characterized by spastic paraparesia and often associated with peripheral adrenal insufficiency in males.
Poorly formed aggregates and reduced levels of spores were apparent in the DZ2 aldA mutant, even after prolonged development.
2
These data indicate that DMSP-ald is an intermediate in DMSP biosynthesis and that the other three compounds are not.
3
Although different X-ALD phenotypes are recognized, little is known about their evolution.
4
However, the mechanisms underlying the brain damage in X-ALD are poorly known.
5
Watch the ALD descend into the belly of the Rosalind Franklin rover.
1
The childhood-onset cerebral form of adrenoleukodystrophy has a devastating neurologic prognosis.
2
A young male patient with adrenoleukodystrophy progressed from the frontal to the parieto-occipital region was reported.
3
Background and purpose: Outcomes following hematopoietic stem cell transplantation for higher risk childhood-onset cerebral adrenoleukodystrophy are variable.
4
X-linked adrenoleukodystrophy is a neurodegenerative disorder affecting the myelin of the nervous system and the adrenal cortex.
5
Conclusions: Gadolinium enhancement intensity on brain MR imaging can be scored simply and reproducibly for cerebral adrenoleukodystrophy.
Ús de adrenomyeloneuropathy en anglès
1
Asymptomatic, adrenomyeloneuropathy and female heterozygote patients had no significant changes in cerebral perfusion.
2
Unfortunately, there is no early method of distinguishing it from the more benign forms of adrenoleukodystrophy, such as adrenomyeloneuropathy.
3
A 39-year-old male showed rapid progression of cerebral white matter involvement after 8 years' duration of adrenomyeloneuropathy.